Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May;59(10):1296-1297.
doi: 10.1111/apt.17973.

Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision?

L A A P Derikx  1 , F Hoentjen  2
Affiliations
Editorial

Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision?

L A A P Derikx et al. Aliment Pharmacol Ther. 2024 May.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330:1841–1845.
    1. Järnerot G, Hertervig E, Friis‐Liby I, Blomquist L, Karlén P, Grännö C, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo‐controlled study. Gastroenterology. 2005;128:1805–1811.
    1. Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, et al. cyclosporine versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open‐label randomised controlled trial. Lancet. 2012;380:1909–1915.
    1. Feuerstein JD, Akbari M, Tapper EB, Cheifetz AS. Systematic review and meta‐analysis of third‐line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis. Ann Gastroenterol. 2016;29:341–347.
    1. Narula N, Fine M, Colombel JF, Marshall JK, Reinisch W. Systematic review: sequential rescue therapy in severe ulcerative colitis: do the benefits outweigh the risks? Inflamm Bowel Dis. 2015;21:1683–1694.

Substances

LinkOut - more resources